Decisions of Extraordinary General Meeting held on 14.08.2018
In accordance with paragraph 126.96.36.199 of the Athens Stock Exchange Regulation, we inform the investment public of the following:
An Extraordinary General Meeting of shareholders of J&P-AVAX SA was scheduled for Tuesday, August 14, 2018 at 10:30 at the Company headquarters, located at 16 Amarousiou-Halandriou Street in Marousi, Greece to discuss the following agenda:
1. Decrease of the nominal value of each common share from €0.58 to €0.30, resulting in the decrease of the nominal value of the Company’s share capital by €21,743,358.00, capitalising an equal amount of accumulated losses.
2. Increase of the share capital of the Company up to the amount of twenty million euro (€20,000,000.00) through a cash issue offering rights of participation to all its shareholders, at an issue price of €0.45 per share for a total of 44,444,444 new common shares
3. Amendment of article 5 of the Corporate Charter.
Participation to the General Meeting amounted to 100 shares or 0.000% of the Company’s total shares. Therefore, the General Meeting lacked the required quorum for allowing shareholders who registered their intention to participate in the meeting after the 10.08.2018 deadline, and proceeding to discussion and vote on the items in the agenda. A new invitation to shareholders for a 2nd repeat general meeting will be announced shortly.